TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: neurocognitive evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Subjects Reporting Fever After MMR Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Onset of Neuromuscular Blocking Agents (NMBAs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Duration of Neuromuscular Blocking Agents (NMBAs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Recovery Index of Neuromuscular Blocking Agents (NMBAs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Aneurysm rebleeding
Endpoint domain: Mortality/survival
Primary endpoint: Attention Deficit and Hyperactivity Rating Scale - 5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in severity of depressive symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cognitive Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life in breast cancer survivors after acupuncture
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Insomnia reduction
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Compartmental distribution of inspired/expired volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parents' decision satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 12 month local tumor progression rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Maximum drug concentration (Cmax) of CDP6038 in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration/time curve from hour 0 to the last quantifiable level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Half life of CDP6038 in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hopkins Verbal Learning Test-Revised (HVLT-R) Total Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Outcomes of face transplantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in spasticity level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in angular kinematic variables during gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in linear kinematic variables during gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rotator cuff compression risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: on-treatment platelet reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Onset of laryngeal edema
Endpoint domain: Adverse events/effects
Primary endpoint: Major adverse peri-intubation events
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of invasive procedures
Endpoint domain: Adverse events/effects
Primary endpoint: Pain Intensity Ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of overall KOOS
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Metabolic state
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Joint Position Sense of the knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Two-year change in systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Nine-year change in systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Myogenic tone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Contraceptive uptake
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Facility Delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exclusive Breastfeeding
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change of AUC of driving pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of detecting RCC recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of severe adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Level of agreement between sonoHSG and HSG results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing potential by 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change from baseline in highest value SUVmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anterior ramus width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posterior ramus width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Standard pharmacokinetic assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Grade 3 or Greater Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: complications from biopsy
Endpoint domain: Adverse events/effects
Primary endpoint: radiation dermatitis severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Preventable locoregional recurrence
Endpoint domain: Mortality/survival
Primary endpoint: HCC recurrence after RFA
Endpoint domain: Mortality/survival
Primary endpoint: retention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of subjects with seroresponse and hSBA titer ≥ 1:8 and ≥ 1:4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of subjects with hSBA titer ≥ 1:5 to N. meningitidis serogroup B strains
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of participants with any adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Non-invasive arterial blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in plasma concentrations of epinephrine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in norepinephrine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in cortisol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Changes in subject health status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Response rate (overall and confirmed)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to fatal or non-fatal stroke/TIA
Endpoint domain: Mortality/survival
Primary endpoint: Kinetics of IVIG-L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Efficacy of IVIG-L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Safety of IVIG-L
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of proximal junctional fracture or instrumentation failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: NAFLD histological changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Cellular infiltrates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Dark-adapted (Scotopic) Full-field Stimulus Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to 95% Healing of the Skin Graft
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Prevalence of hypovitaminosis D
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of Hyperparathyroidism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Prevalence of Hypomagnesemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fibroblast Growth Factor 23 (FGF23)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Alpha Klotho
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Safety of bone marrow stem cell transplantation
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Who Responded to Therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knee Injury and Osteoarthritis Outcome Score (KOOS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: International Knee Documentation Committee (IKDC) score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence of severe RSV infection
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivity and specificity of MRI and PET-CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictive values of MRI and PET-CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of MRI and PET-CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of Acoustic Respiration Rate (RRa)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total Patient Pain Relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative Latent Safety Threats (LST)
Endpoint domain: Adverse events/effects
Primary endpoint: Identification of genetic variations associated with treatment response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Identification of genetic variations associated with adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Identification of genetic variations associated with risk of acute lymphoblastic leukemia (ALL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cerebral Oximetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygen arterial saturation (OSat)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of all fractions of IMRT TBI
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Grade 3 or 4 chemotherapy toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: airway inflammation measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change of UPDRS Part III score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes of tremor, rigidity, bradykinesia and postural stability scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: ischemia stroke
Endpoint domain: Mortality/survival
Primary endpoint: Arrest of caries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Intellectual Function of Children at 5 Years of Age
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of complete wound closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Time to AF and AT recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Difference in false positive DXM-tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of candesartan in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t of candesartan in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial Image Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Correlation coefficient with histological score of hepatic steatosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hypertensive disorders of pregnancy incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Percentage of recovery from coma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of photodynamic therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline of Sore Throat Pain Intensity Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Numeric Pain Rating Scale (NPRS)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Plasma pharmacokinetics (AUCss,τ) of Cilostazol and Active metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma pharmacokinetics (Css,max) of Cilostazol and Active metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma pharmacokinetics (AUCss,τ) of Rosuvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma pharmacokinetics (Css,max) of Rosuvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood glucose control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of acute grade >= 2 genitourinary toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of Handwashing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Frequency of Face Touching
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Frequency of Hand Sanitizer Use
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Frequency of Social Event Avoidance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Frequency of Staying Home From Work/School
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Frequency of Mask Wearing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Activity of brown adipose tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Exogenous insulin needs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pharmacokinetic parameters for tamsulosin HCl
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence or Absence of Germinal Centers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total protein concentration in human milk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Rankin Scale (mRS) scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: National Institutes of Health Stroke Scale (NIHSS) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Number of Lucentis® Injections
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 3-years disease free survival
Endpoint domain: Mortality/survival
Primary endpoint: Horizontal probing depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tomographic Bone filling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Error in prediction of surgical target location
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Frontal Assessment Battery (FAB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Toulouse-Piéron Cancellation Test (TP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in physical pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: End-stage renal disease or death
Endpoint domain: Mortality/survival
Primary endpoint: TVF at 12 months after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety assessed by Laboratory tests
Endpoint domain: Adverse events/effects
Primary endpoint: Safety assessed by medical evaluations
Endpoint domain: Adverse events/effects
Primary endpoint: Safety assessed by ECG results
Endpoint domain: Adverse events/effects
Primary endpoint: Blood glucose Area Under the Curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Average Daily Pain Score (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Average Pain Score (ECOG Neuropathy Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the sperm epigenome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of pre-specified administration-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Mitochondrial DNA (mtDNA) level from day 1 to day 5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concerned Significant Other Status
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Time to administration of an appropriate sepsis bundle of care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic performance for coronary artery obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Safety of Visipaque-enhanced CTA images
Endpoint domain: Adverse events/effects
Primary endpoint: Pain measurement using Numerical Rating Scale (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tonometer reading
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Response in HCC (CR or PR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: 1 year outcome as measured by the Glasgow Outcome Scale (extended version)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: PTSD-Checklist-5 (PCL-5)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Safety-Suicidal ideation item on the Beck Depression Inventory-II (BDI-II)
Endpoint domain: Adverse events/effects
Primary endpoint: Perimetric Mean Deviation (PMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Inter-reader agreement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in body composition (fat and fat-free mass in kg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depth of chest compression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: adaptive immune response to YF vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Buproprion Area Under the Concentration Time Curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of Myocardial Infarction and Congestive Heart Failure (CHF)
Endpoint domain: Mortality/survival
Primary endpoint: leflunomide dose modifications
Endpoint domain: Adverse events/effects
Primary endpoint: discontinuation of leflunomide
Endpoint domain: Adverse events/effects
Primary endpoint: Cardiovascular Risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Knee joint position sense
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: One Leg stance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bruch's Membrane Opening Minimum Rim Width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease-Free Survival (DFS) Events
Endpoint domain: Mortality/survival
Primary endpoint: Ocular itching and redness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in preparation for consideration of clinical trials
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants With Flare Up of Crohn's Disease Through Month 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Quality of Life in Patients Taking Dietary Treatments
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Safety of Dietary Treatments
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive and negative predictive values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Recovery-40 score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Return of motor and sensory function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Osteoporosis diagnosis (T-score < -2.5 or osteoporosis fracture)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability and feasibility
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Brain Reward Circuit Activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes